Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Lot TS10626 · tested by Kovera Labs · sold by Orbitrex Peptides
View all TesamorelinCOAs & purity data →Bare numerics show the raw value without a Pass/Fail status because the USP <232> Class limit depends on dose form. Comparator entries (<, ≤) resolve to Pass since they signal below-limit without needing a threshold table.
355 COAs indexed · std dev 0.28% · US
The lot number TS10626 also appears on 1 COA from other vendors. Same-lot-across-multiple-vendors is a cross-vendor signal we flag on the Forgery Map.
| Vendor | Lab | Peptide | Purity | Provenance |
|---|---|---|---|---|
| Synthesis Peptides | Kovera Labs | Tesamorelin | 99.36% | Confirmed by Kovera Labs |
Uploaded by the vendor and confirmed by Kovera Labs.
First indexed 2026-05-26
View originalVendors who reference this batch can drop a one-line script. The verified-COA badge renders inline and the QR scans back to this page.
Disclosed Labs<script src="https://www.disclosedlabs.com/widget.js" data-lot="TS10626"></script>Vendor's product page at the time of testing showed: 10mg per vial. Captured 2026-06-25.
Live product pageThis certificate is third-party content submitted by a vendor or laboratory, or collected from a public source; Disclosed Labs does not author it and does not warrant its accuracy or authenticity. Any signals or scores shown are our opinion based on the data available to us. If you are the vendor or issuing lab and believe this report is inaccurate, forged, or should be removed, request a correction or removal — see our Copyright & Takedown Policy.